Tenax Therapeutics announced the appointment of Javed Butler, M.D., M.P.H, M.B.A., to the Company’s PH-HFpEF Scientific Advisory Board, SAB. Javed Butler, M.D., M.P.H., M.B.A., is the President of the Baylor Scott and White Research Institute and Senior Vice President for Baylor Scott and White Health.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TENX:
- Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board
- Biotech Alert: Searches spiking for these stocks today
- Tenax Therapeutics cleared for TNX-103 Phase 3 trials, says Roth MKM
- Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
- Tenax Therapeutics’ IND application for TNX-103 cleared by FDA
